Follow @ebcapital
Recent articles
3 Top Mid-Cap Stocks to Buy Right Now
Adding these growing mid-cap companies to portfolios this month could pay off.
How Doctors Treat Dementia and Lung Cancer Could Be About to Change
Patients have new hope following successful trials in dementia-related psychosis and lung cancer treatments.
Why Amgen's Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemy
Amgen is acquiring Otezla, and The Medicines Company unveils stellar data for its cholesterol treatment.
Why Global Blood Therapeutics Stock Jumped 10.9% Today
The company's most advanced drug has taken a step toward FDA approval.
Why InMode Shares Surged 12.9% Today
Wall Street is increasingly optimistic about this medical device company.
3 Top Dividend Stocks to Buy Right Now
Income-focused investors should be able to count on these companies: a fast-food giant, a media empire, and a REIT in an unusual niche.
3 Stocks to Buy and Hold for the Next 50 Years
Not every company deserves to be in your 50-year portfolio, but owning these three could pay off handsomely.
3 Stocks to Hold for the Next 20 Years
Long-term catalysts could make these top stocks a savvy addition to portfolios.
3 Growth Stocks to Buy and Hold for the Next 50 Years
Adding these top stocks to long-haul portfolios now could be profit-friendly.
How Online Platforms Are Disrupting the $335 Billion Caregivers Market
These companies are making it easier for people to find caregivers for their aging parents and young children.
Why Elastic Is Soaring 14.7% Today
The enterprise search company's fiscal first-quarter results are sparking investor optimism.
A Breach of Trust? Here's Why the FDA's Taking Aim at Novartis' AveXis
What Novartis' misstep means to investors, plus how Exact Sciences is trying to lock up the genetic testing market.
Biopharma Tie-Ups and Quebecois Weed Woes
HEXO could run into some legal troubles soon, and short sellers are eagerly awaiting a drop.
14 Top Small-Cap Stocks to Buy Now
If you don't own these up-and-coming small companies in your investment portfolio yet, you could be missing out on a big opportunity for market-beating returns.
Why Portola Pharmaceuticals Is Rocketing 10.9% Higher Today
The company's second-quarter revenue is sparking optimism for future growth.
Why Insulet's Shares Are Rocketing 20.8% Higher Today
The insulin pump maker's second-quarter financial results are sparking optimism.
3 Growth Stocks for In-the-Know Investors
These stocks might not be household names, but they could still generate market-beating returns.
How to Invest in Small-Cap Stocks
Here's what you should know if you want to buy and sell small-cap companies.
3 Stocks Anyone Can Understand
Investing in simple businesses like these could be key to market-beating returns.
3 Stocks to Recession-Proof Your Portfolio
Owning these big-cap stocks the next time the economy sours could be profit-friendly.